Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Dividend Yield, History & Forecast
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. market capitalization is approximately $502M.
Frequently Asked Questions about Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
Is Contineum Therapeutics, Inc. Class A Common Stock a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Contineum Therapeutics, Inc. Class A Common Stock in?▾
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) operates in the Healthcare sector, specifically the Biotechnology industry.
